Featured Research

from universities, journals, and other organizations

Sibling Cord Blood May Offer Best Match Chance For Some Patients

Date:
December 7, 1998
Source:
Duke University Medical Center
Summary:
Children needing bone marrow transplants may find their best chance in umbilical cord blood from a sibling, even if the transplant is only partially matched to the recipient's blood type, according to Duke researchers.

MIAMI -- Children needing bone marrow transplants may find their best chance in umbilical cord blood from a sibling, even if the transplant is only partially matched to the recipient's blood type, according to Duke researchers.

Researchers have found cord blood can restore bone marrow when the recipient/donor type match is not as close as that necessary in bone marrow transplants. A bone marrow transplant generally is successful only with a perfect match of all six antigens. Successful cord blood transplants from unrelated donors have been performed when only four of six antigens matched.

Four children ranging from 2 1/2 to 6 1/2 years old, all suffering from inherited blood diseases that lead to death in childhood, received "haplo-identical," or half matched, sibling umbilical cord blood transplants to replace their bone marrow. None of the patients who had half-match transplants from siblings had serious graft versus host disease. The transplants were successful in three of the four patients, who are alive and well 12 to 29 months after transplant.

The findings were prepared for presentation Friday at the annual conference of the American Society of Hematology.

The success offers hope for patients who otherwise may not find a suitable match for transplant, said Dr. Paul Martin of Duke's pediatric bone marrow and cord blood transplant program. Three out of four siblings will be at least a 3/6, or half match for transplantation, he said.

"Harvesting a sibling's blood may offer a curative therapy in three out of four cases," he said.

The next step, he said, will be further investigation in the use of haplo-identical cord blood transplant in patients with cancer.


Story Source:

The above story is based on materials provided by Duke University Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Duke University Medical Center. "Sibling Cord Blood May Offer Best Match Chance For Some Patients." ScienceDaily. ScienceDaily, 7 December 1998. <www.sciencedaily.com/releases/1998/12/981207074442.htm>.
Duke University Medical Center. (1998, December 7). Sibling Cord Blood May Offer Best Match Chance For Some Patients. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/1998/12/981207074442.htm
Duke University Medical Center. "Sibling Cord Blood May Offer Best Match Chance For Some Patients." ScienceDaily. www.sciencedaily.com/releases/1998/12/981207074442.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins